Zivo Bioscience, Inc.
ZIVO
$11.99
-$2.92-19.58%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 185.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 185.71% | |||
| Cost of Revenue | -- | 185.07% | |||
| Gross Profit | -- | 184.21% | |||
| SG&A Expenses | 4.33% | -28.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 149.57% | -26.41% | |||
| Operating Income | -163.64% | 29.36% | |||
| Income Before Tax | -162.97% | 29.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -162.97% | 29.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -162.97% | 29.41% | |||
| EBIT | -163.64% | 29.36% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -148.56% | 32.08% | |||
| Normalized Basic EPS | -148.55% | 32.07% | |||
| EPS Diluted | -148.56% | 32.08% | |||
| Normalized Diluted EPS | -148.55% | 32.07% | |||
| Average Basic Shares Outstanding | 5.81% | 3.92% | |||
| Average Diluted Shares Outstanding | 5.81% | 3.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||